By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS



Segment
Drug Discovery





Company News
PTC Therapeutics, Inc. (PTCT) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 8:58:07 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/5/2015 8:13:20 AM
PTC Therapeutics, Inc. (PTCT) Begins Rolling NDA Submission To The FDA For Translarna To Treat Duchenne Muscular Dystrophy 12/23/2014 7:57:36 AM
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014 8:03:40 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/18/2014 7:44:02 AM
PTC Therapeutics, Inc. (PTCT) Announces Launch Of Translarna (ataluren) In Germany 12/3/2014 11:50:18 AM
PTC Therapeutics, Inc. (PTCT) Announces CEO, Dr. Stuart Peltz Recipient Of The New Jersey Technology Council's 2014 Legend Of Technology Award 11/21/2014 10:35:44 AM
PTC Therapeutics, Inc. (PTCT) Release: Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial In Patients With SMA 11/19/2014 11:24:41 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 11/17/2014 3:32:46 PM
PTC Therapeutics, Inc. (PTCT) Appoints Dr. Tuyen Ong SVP, Head Of Clinical Development And Translational Research 11/17/2014 12:07:11 PM
12345678910...
//-->